More importantly, we define a critical role for circSMARCA5 in the regulation of DNA damage repair capacity and the drug sensitivity of breast cancer cells in vitro and in vivo through the negative regulation of its parent gene SMARCA5. The gene discussed is SMARCA5; the disease is breast carcinoma.